Evidence map›Paper›PMID 38607085›Full record

ArticleCells2024

Residual Cystine Transport Activity for Specific Infantile and Juvenile

Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers

Open access · goldAbstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Louise MedaerLaboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-2998-7358
Dries DavidLaboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-4059-6326
Maxime SmitsLaboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.ORCID 0009-0004-0997-8993
Elena LevtchenkoDepartment of Paediatric Nephrology & Development and Regeneration, University Hospitals Leuven & KU Leuven, 3000 Leuven, Belgium.
Maurilio SampaolesiTranslational Cardiology Laboratory, Department of Development and Regeneration, Stem Cell Institute, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-2422-3757
Rik GijsbersLaboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-0191-3904
Rega Institute for Medical Research · BEKU Leuven · BEUniversity of Amsterdam · NL

Funding

Cystinosis Ireland CI-CFUK 2021-02EC HORIZON-MSCA-2023-DN 10111988Fonds Wetenschappelijk Onderzoek 180936-1S22921N-SWFonds Wetenschappelijk Onderzoek G056521NHORIZON-MSCA-2023-DN-JD 101120108KU Leuven C1 grant C14/17/11
6 · The paper itself

Abstract

Cystinosis is a rare, autosomal recessive, lysosomal storage disease caused by mutations in the gene

Indexed as

Amino Acid Transport Systems, NeutralCystinosisCysteamineCystineHumansMutationAmino Acid Transport Systems, NeutralCTNS protein, humanCysteamineCystineCTNSmutantscystinosisgene therapykidney diseaseviral vectors

Identifiers

PMID38607085
PMCPMC11011962
OpenAlexW4394566126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.